These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15618625)

  • 41. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
    He Q; Riley RT; Sharma RP
    Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonionic surfactants increase digoxin absorption in Caco-2 and MDCKII MDR1 cells: Impact on P-glycoprotein inhibition, barrier function, and repeated cellular exposure.
    Al-Ali AAA; Steffansen B; Holm R; Nielsen CU
    Int J Pharm; 2018 Nov; 551(1-2):270-280. PubMed ID: 30240828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for a non-MDR1 component in digoxin secretion by human intestinal Caco-2 epithelial layers.
    Lowes S; Cavet ME; Simmons NL
    Eur J Pharmacol; 2003 Jan; 458(1-2):49-56. PubMed ID: 12498906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyroid hormone regulates the expression and function of P-glycoprotein in Caco-2 cells.
    Nishio N; Katsura T; Inui K
    Pharm Res; 2008 May; 25(5):1037-42. PubMed ID: 18004648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):780-6. PubMed ID: 12134947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans.
    Becquemont L; Glaeser H; Drescher S; Hitzl M; Simon N; Murdter TE; Heinkele G; Hofmann U; Schaefer C; Burk O; Verstuyft C; Eichelbaum M; Fromm MF
    Clin Pharmacol Ther; 2006 May; 79(5):449-60. PubMed ID: 16678547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2.
    Goto M; Masuda S; Saito H; Inui K
    Biochem Pharmacol; 2003 Jul; 66(1):163-70. PubMed ID: 12818377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.
    Horie K; Tang F; Borchardt RT
    Pharm Res; 2003 Feb; 20(2):161-8. PubMed ID: 12636153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein.
    Mayer U; Wagenaar E; Beijnen JH; Smit JW; Meijer DK; van Asperen J; Borst P; Schinkel AH
    Br J Pharmacol; 1996 Nov; 119(5):1038-44. PubMed ID: 8922756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
    Wu X; Whitfield LR; Stewart BH
    Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux.
    Pan G; Li T; Zeng Q; Wang X; Zhu Y
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26861264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase.
    Min JK; Yoo HS; Lee EY; Lee WJ; Lee YM
    Anal Biochem; 2002 Apr; 303(2):167-75. PubMed ID: 11950216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Type C Niemann-Pick disease: a murine model of the lysosomal cholesterol lipidosis accumulates sphingosine and sphinganine in liver.
    Goldin E; Roff CF; Miller SP; Rodriguez-Lafrasse C; Vanier MT; Brady RO; Pentchev PG
    Biochim Biophys Acta; 1992 Aug; 1127(3):303-11. PubMed ID: 1324734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein.
    Wandel C; Kim R; Wood M; Wood A
    Anesthesiology; 2002 Apr; 96(4):913-20. PubMed ID: 11964599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide.
    Ahn EH; Schroeder JJ
    Anticancer Res; 2010 Jul; 30(7):2881-4. PubMed ID: 20683027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of sphinganine and sphingosine as human breast cancer chemotherapeutic and chemopreventive agents.
    Ahn EH; Chang CC; Schroeder JJ
    Exp Biol Med (Maywood); 2006 Nov; 231(10):1664-72. PubMed ID: 17060688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fumonisin B1 exposure and its selective effect on porcine jejunal segment: sphingolipids, glycolipids and trans-epithelial passage disturbance.
    Loiseau N; Debrauwer L; Sambou T; Bouhet S; Miller JD; Martin PG; Viadère JL; Pinton P; Puel O; Pineau T; Tulliez J; Galtier P; Oswald IP
    Biochem Pharmacol; 2007 Jun; 74(1):144-52. PubMed ID: 17499218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas.
    Nakamura T; Sakaeda T; Ohmoto N; Tamura T; Aoyama N; Shirakawa T; Kamigaki T; Nakamura T; Kim KI; Kim SR; Kuroda Y; Matsuo M; Kasuga M; Okumura K
    Drug Metab Dispos; 2002 Jan; 30(1):4-6. PubMed ID: 11744604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.